Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Clinical Study Evaluating Safety, Tolerability, and Efficacy of IAP0971 in Advanced Tumors

NCT06581419 is registered in ClinicalTrials.gov with SUNHO（China）BioPharmaceutical CO., Ltd. as lead sponsor.

NCT NCT06581419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Clinical Study Evaluating Safety, Tolerability, and Efficacy of IAP0971 in Advanced Tumors
Lead sponsor
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 31, 2024
Completion date
August 1, 2029
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant neoplasm, advanced or metastatic non-small cell lung cancer